Corvex Management LP
CIK 1535472 · last filed 2026-05-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
WGSWW price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
NEW YORK, NY 10065
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GeneDx Holdings Corp. (WGSWW) Delisted | Director | 4,785,834 | $0.00 | $957 | $138.36M | 6 | 2026-05-15 |
| VSTS | Director | 19,620,352 | $14.96 | $293.52M | $104.87M | 7 | 2025-12-17 |
| ENERGEN CORP (EGN) Delisted | 10%+ Owner | 9,710,474 | — | — | $9.24M | 1 | 2018-01-02 |
Recent Filings · Page 2 of 4
31 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-09 | MGM | Notice (144) | −37,500 | -$1.33M | EDGAR |
| 2025-12-17 | VSTS | Buy (P) | +2,020,128 | $13.75M | EDGAR |
| 2025-10-06 | GeneDx Holdings Corp. (WGSWW) Delisted | — | — | $0 | EDGAR |
| 2025-09-11 | MGM | Notice (144) | −242,000 | -$8.70M | EDGAR |
| 2025-06-13 | MGM | Notice (144) | −60,000 | -$1.95M | EDGAR |
| 2025-05-16 | GeneDx Holdings Corp. (WGSWW) Delisted | Buy (P) | +100,000 | $6.02M | EDGAR |
| 2025-05-12 | VSTS | Buy (P) | +1,990,694 | $12.22M | EDGAR |
| 2025-05-12 | GeneDx Holdings Corp. (WGSWW) Delisted | Buy (P) | +200,000 | $11.20M | EDGAR |
| 2025-05-06 | GeneDx Holdings Corp. (WGSWW) Delisted | Grant (A) | +869,696 | $55.60M | EDGAR |
| 2024-12-13 | MGM | Notice (144) | −51,000 | -$1.87M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.